-
1
-
-
84897449259
-
-
National Center for Chronic Disease Prevention and Health Promotion, ed. Atlanta, GA: Centers for Disease Control and Prevention, Division of Diabetes Translation
-
National Center for Health Statistics, Division of Health Interview Statistics. In: National Center for Chronic Disease Prevention and Health Promotion, ed. Crude and age-adjusted percentage of civilian noninstitutionalized adults with diagnosed diabetes, United States, 1980-2010. Atlanta, GA: Centers for Disease Control and Prevention, Division of Diabetes Translation, 2012.
-
(2012)
Crude and age-adjusted percentage of civilian noninstitutionalized adults with diagnosed diabetes, United States, 1980-2010
-
-
-
2
-
-
85042572788
-
-
(accessed 12 Oct 2014)
-
http://www.cdc.gov/nchs/nhanes/about_nhanes.Htm (accessed 12 Oct 2014).
-
-
-
-
3
-
-
64349083605
-
Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006
-
Cheung BMY, Ong KL, Cherny SS, et al. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med 2009;122:443-53.
-
(2009)
Am J Med
, vol.122
, pp. 443-453
-
-
Cheung, B.M.Y.1
Ong, K.L.2
Cherny, S.S.3
-
4
-
-
84882254968
-
The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010
-
Stark Casagrande S, Fradkin JE, Saydah SH, et al. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care 2013;36:2271-9.
-
(2013)
Diabetes Care
, vol.36
, pp. 2271-2279
-
-
Stark Casagrande, S.1
Fradkin, J.E.2
Saydah, S.H.3
-
6
-
-
84876550739
-
Achievement of goals in US diabetes care, 1999-2010
-
Ali MK, Bullard KM, Saaddine JB, et al. Achievement of goals in US diabetes care, 1999-2010. N Engl J Med 2013;368:1613-24.
-
(2013)
N Engl J Med
, vol.368
, pp. 1613-1624
-
-
Ali, M.K.1
Bullard, K.M.2
Saaddine, J.B.3
-
7
-
-
84898602820
-
Changes in diabetes-related complications in the United States, 1990-2010
-
Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med 2014;370:1514-23.
-
(2014)
N Engl J Med
, vol.370
, pp. 1514-1523
-
-
Gregg, E.W.1
Li, Y.2
Wang, J.3
-
8
-
-
77449156169
-
Integrated delivery systems: The cure for fragmentation
-
Enthoven AC. Integrated delivery systems: the cure for fragmentation. Am J Manag Care 2009;15(10 Suppl):S284-90.
-
(2009)
Am J Manag Care
, vol.15
, Issue.10
, pp. S284-S290
-
-
Enthoven, A.C.1
-
9
-
-
84857146745
-
Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study
-
Kho AN, Hayes MG, Rasmussen-Torvik L, et al. Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study. J Am Med Inform Assoc 2012;19:212-18.
-
(2012)
J Am Med Inform Assoc
, vol.19
, pp. 212-218
-
-
Kho, A.N.1
Hayes, M.G.2
Rasmussen-Torvik, L.3
-
10
-
-
84892649479
-
Standards of medical care in diabetes-2014
-
American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care 2014; 37(Suppl 1):S14-80.
-
(2014)
Diabetes Care
, vol.37
, pp. S14-S80
-
-
-
11
-
-
38349102796
-
Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization
-
Young BA, Lin E, Von Korff M, et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care 2008;14:15-23.
-
(2008)
Am J Manag Care
, vol.14
, pp. 15-23
-
-
Young, B.A.1
Lin, E.2
Von Korff, M.3
-
12
-
-
78651338445
-
Standards of medical care in diabetes-2011
-
American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011;34(Suppl 1):S11-61.
-
(2011)
Diabetes Care
, vol.34
, pp. S11-S61
-
-
-
14
-
-
84864349212
-
Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: A retrospective analysis
-
Pantalone KM, Kattan MW, Yu C, et al. Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis. Diabetes Obes Metab 2012;14:803-9.
-
(2012)
Diabetes Obes Metab
, vol.14
, pp. 803-809
-
-
Pantalone, K.M.1
Kattan, M.W.2
Yu, C.3
-
15
-
-
17144384777
-
Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with type 2 diabetes
-
Johnson JA, Simpson SH, Toth EL, et al. Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with type 2 diabetes. Diabet Med 2005;22:497-502.
-
(2005)
Diabet Med
, vol.22
, pp. 497-502
-
-
Johnson, J.A.1
Simpson, S.H.2
Toth, E.L.3
-
16
-
-
34250212715
-
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
-
Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007;356:2457-71.
-
(2007)
N Engl J Med
, vol.356
, pp. 2457-2471
-
-
Nissen, S.E.1
Wolski, K.2
-
17
-
-
84862684037
-
The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: Nested case-control study
-
Azoulay L, Yin H, Filion KB, et al. The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study. BMJ 2012;344:e3645.
-
(2012)
BMJ
, vol.344
-
-
Azoulay, L.1
Yin, H.2
Filion, K.B.3
-
18
-
-
26244453309
-
PROactive investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (PROspective pioglitAzone clinical trial in macroVascular events): A randomised controlled trial
-
Dormandy JA, Charbonnel B, Eckland DJ, et al. PROactive investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (PROspective pioglitAzone clinical trial in macroVascular events): a randomised controlled trial. Lancet 2005;366:1279-89.
-
(2005)
Lancet
, vol.366
, pp. 1279-1289
-
-
Dormandy, J.A.1
Charbonnel, B.2
Eckland, D.J.3
-
19
-
-
79956217900
-
Risk of bladder cancer among diabetic patients treated with pioglitazone: Interim report of a longitudinal cohort study
-
Lewis JD, Ferrara A, Peng T, et al. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care 2011;34:916-22.
-
(2011)
Diabetes Care
, vol.34
, pp. 916-922
-
-
Lewis, J.D.1
Ferrara, A.2
Peng, T.3
-
20
-
-
77955376918
-
Prevalence of diabetic retinopathy in the United States, 2005-2008
-
Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 2010;304:649-56.
-
(2010)
JAMA
, vol.304
, pp. 649-656
-
-
Zhang, X.1
Saaddine, J.B.2
Chou, C.F.3
|